Samuel Agus

Samuel Agus

Company: Biophytis

Job title: Chief Medical Officer


Samuel Agus serves as Chief Medical Officer for Biophytis, a company that specializes in aging sciences, since July 2018. Prior to that, he served at various leadership positions in clinical development and medical affairs, in pharmaceutical and biotech companies, such as Teva Pharmaceuticals industries, Solvay Pharmaceuticals, Abbott, Shire, H. Lundbeck A/S. and Hansa Biopharma. Dr. Agus holds a doctorate in Medicine from The Hebrew University of Jerusalem. He is a board-certified neurologist (from Israel) and has had academic training in biostatistics and bioinformatics.


How to Select the Right Participants for Longevity Clinical Trials? 4:30 pm

Examine why it’s important to select the right participants Explore what the considerations are for choosing suitable patient Evaluate biotype verses phenotype Discuss the clinical relevance and clinical significance of selecting the correct patient poolRead more

day: Day Two

Panel Discussion: A Therapeutic Revolution Against Aging – Bridging the Gaps & Opportunities 4:50 pm

Examining what we do and do not know about the aging process Exploring the targeting of aging as a disease vs. aging as a common factor for different conditions Analyzing the current R&D landscape for anti-aging therapeutics Discussing recent breakthroughs and the growing interest in this space – attracting funding/ partnerships, important learnings to date…Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.